Drew Weissman

E157144

human immunologist physician-scientist professor

Drew Weissman is an American physician-scientist best known for his pioneering work on mRNA technology that enabled the development of COVID-19 vaccines.

Try in SPARQL Jump to: Surface forms Disambiguation Statements Elicitation Referenced by

All labels observed (1)

Label	Occurrences
Drew Weissman canonical	6

How this entity was disambiguated

This entity first appeared as the object of triple T1347021 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.

NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07

Target entity: Drew Weissman
Context triple: [John Scott Medal, notableRecipient, Drew Weissman]

A. Katalin Karikó
Katalin Karikó is a Hungarian-American biochemist whose pioneering work on mRNA technology enabled the development of several COVID-19 vaccines and earned her a share of the 2023 Nobel Prize in Physiology or Medicine.
B. Peter C. Doherty
Peter C. Doherty is an Australian immunologist and Nobel Prize laureate renowned for his groundbreaking work on how the immune system recognizes virus-infected cells.
C. Harold Varmus
Harold Varmus is a Nobel Prize–winning American cancer researcher and former director of the National Institutes of Health and the National Cancer Institute.
D. Jules Hoffmann
Jules Hoffmann is a Luxembourg-born French immunologist and Nobel Prize laureate renowned for his pioneering work on the innate immune system, particularly in insects.
E. Stuart L. Schreiber
Stuart L. Schreiber is an influential American chemist renowned for pioneering work in chemical biology and diversity-oriented synthesis, which has profoundly impacted drug discovery and biological research.
F. None of above. chosen
G. Unsure - the case is ambiguous/there is not enough information to decide.

NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07

Target entity: Drew Weissman
Target entity description: Drew Weissman is an American physician-scientist best known for his pioneering work on mRNA technology that enabled the development of COVID-19 vaccines.

A. Katalin Karikó
Katalin Karikó is a Hungarian-American biochemist whose pioneering work on mRNA technology enabled the development of several COVID-19 vaccines and earned her a share of the 2023 Nobel Prize in Physiology or Medicine.
B. Peter C. Doherty
Peter C. Doherty is an Australian immunologist and Nobel Prize laureate renowned for his groundbreaking work on how the immune system recognizes virus-infected cells.
C. Harold Varmus
Harold Varmus is a Nobel Prize–winning American cancer researcher and former director of the National Institutes of Health and the National Cancer Institute.
D. Jules Hoffmann
Jules Hoffmann is a Luxembourg-born French immunologist and Nobel Prize laureate renowned for his pioneering work on the innate immune system, particularly in insects.
E. Stuart L. Schreiber
Stuart L. Schreiber is an influential American chemist renowned for pioneering work in chemical biology and diversity-oriented synthesis, which has profoundly impacted drug discovery and biological research.
F. None of above. chosen

Statements (44)

Predicate	Object
instanceOf	human ⓘ immunologist ⓘ physician-scientist ⓘ professor ⓘ
academicDegree	Bachelor’s degree from Brandeis University ⓘ MD from Boston University ⓘ PhD from Boston University ⓘ
awardReceived	BBVA Foundation Frontiers of Knowledge Award ⓘ surface form: BBVA Foundation Frontiers of Knowledge Award in Biomedicine Breakthrough Prize in Life Sciences ⓘ John Scott Award ⓘ Lasker~DeBakey Clinical Medical Research Award ⓘ surface form: Lasker–DeBakey Clinical Medical Research Award Louisa Gross Horwitz Prize ⓘ Nobel Prize in Physiology or Medicine ⓘ Princess of Asturias Award for Technical and Scientific Research ⓘ
coAuthorWith	Katalin Karikó ⓘ
countryOfCitizenship	United States of America ⓘ
educatedAt	Boston University ⓘ Brandeis University ⓘ
employer	University of Pennsylvania ⓘ
familyName	Weissman ⓘ
fieldOfWork	immunology ⓘ mRNA technology ⓘ vaccine development ⓘ
givenName	Drew ⓘ
hasResearchInterest	RNA therapeutics ⓘ infectious diseases ⓘ vaccine immunology ⓘ
influenced	development of Moderna COVID-19 vaccine ⓘ development of Pfizer–BioNTech COVID-19 vaccine ⓘ
knownFor	collaboration with Katalin Karikó on mRNA research ⓘ
languageSpoken	English ⓘ
memberOf	faculty of the University of Pennsylvania ⓘ
name	Drew Weissman self-link ⓘ
notableAchievement	helped enable rapid development of mRNA-based COVID-19 vaccines during the COVID-19 pandemic ⓘ
notableFor	development of mRNA technology enabling COVID-19 vaccines ⓘ pioneering work on nucleoside-modified mRNA ⓘ
notableWork	discovery that nucleoside modifications reduce mRNA immunogenicity ⓘ
occupation	immunologist ⓘ physician ⓘ scientist ⓘ
positionHeld	Director of the Penn Institute for RNA Innovation ⓘ Professor of Medicine at the University of Pennsylvania ⓘ
sexOrGender	male ⓘ
workplace	Perelman School of Medicine at the University of Pennsylvania ⓘ

How these facts were elicited

Referenced by (6)

Full triples — surface form annotated when it differs from this entity's canonical label.

John Scott Medal → notableRecipient → Drew Weissman ⓘ

Katalin Karikó → sharesAwardWith → Drew Weissman ⓘ

Robert Koch Prize → notableLaureate → Drew Weissman ⓘ

Drew Weissman → name → Drew Weissman self-link ⓘ

Karikó → notableStudentOrCollaborator → Drew Weissman ⓘ

subject surface form: Katalin Karikó

Karikó → nobelPrizeSharedWith → Drew Weissman ⓘ